跳至主要内容
临床试验/ACTRN12618001138279
ACTRN12618001138279已完成未知

A retrospective cross-sectional cohort trial assessing the implications of MTHFR polymorphisms on DNA methylation and platinum resistance in ovarian cancer patients

Endeavour College of Natural Health0 个研究点目标入组 25 人开始时间: 2018年7月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
25

研究概览

简要总结

The results of this trial revealed strong associations between dietary B6, B12, zinc and folate intakes in heterozygous A1298C and C677T carriers and platinum response. There is also an association between serum folate, homocysteine, dietary zinc, B12 intakes and platinum sensitivity in participants without a mutation. Further research is required to understand the direction the association flows in order to be able to provide any sound nutritional recommendations, however this study provides a foundation for future research on the role of diet on platinum response in epithelial ovarian cancer patients in relation to MTHFR polymorphisms. Furthermore, the high prevalence of MTHFR mutations in this population may require further investigation into the role of these polymorphisms in the development and/or progression of ovarian cancer. These results require studies on a larger group of participants to confirm the findings shown here.

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
Female

入选标准

  • Diagnosed with ovarian, fallopian tube, epithelial or peritoneal cancer
  • Completed first line platinum therapy
  • Diagnosed with refractory/resistant disease or platinum sensitive disease a minimum of 6 months after platinum therapy

排除标准

  • Non-English speaking
  • Never received a platinum drug for ovarian cancer diagnosis

研究者

发起方
Endeavour College of Natural Health

相似试验